USPH Form 144: Insider Plans to Sell 600 Shares Valued $49,026
US Physical Therapy Inc (USPH) Form 144 notice: The filing reports a proposed sale of 600 shares of Common stock through J.P.
Rhea-AI Filing Summary
US Physical Therapy Inc (USPH) Form 144 notice: The filing reports a proposed sale of 600 shares of Common stock through J.P. Morgan Securities LLC with an aggregate market value of $49,026, planned for approximately 09/11/2025 on the NYSE. The shares were acquired by vesting: 1,653 shares vested on 08/20/2025 from restricted stock grants issued between 05/16/2023 and 05/20/2025, with the acquisition characterized as payment for services rendered. The filing also discloses a prior sale of 400 shares on 06/12/2025 by Nancy Ham, generating $31,204 in gross proceeds. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine insider sale notice showing vested restricted shares and a planned small sale on the NYSE.
The Form 144 is a procedural disclosure required when insiders propose to sell restricted or control securities under Rule 144. This filing shows 1,653 vested shares acquired on 08/20/2025 and a planned brokered sale of 600 shares via J.P. Morgan on 09/11/2025. The figures reported are modest relative to typical market capitalizations and the filing includes the required representation about lack of undisclosed material adverse information. From a compliance perspective, the form appears to provide the necessary acquisition and historical sale details.
TL;DR: Disclosure indicates small insider liquidity activity; no material operational or financial signals are presented.
The notice documents a planned sale of 600 shares valued at $49,026 and a prior sale of 400 shares for $31,204. The vested shares (1,653) stem from restricted grants dating from 2023–2025 and were paid as services. These transactions are routine compensation liquidation events and, standing alone, do not provide substantive information about company performance or prospects. Impact on investors is likely neutral absent additional disclosure.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Does the filing disclose any recent sales by the seller?
Which broker is handling the proposed sale in the Form 144?
Does the Form 144 include any statement about undisclosed material information?
AI-generated analysis. How Rhea-AI works. Not financial advice.